Bone Biologics (BBLG) Return on Assets (2016 - 2017)

Bone Biologics has reported Return on Assets over the past 2 years, most recently at 0.06% for Q4 2017.

  • Quarterly Return on Assets rose 29.0% to 0.06% in Q4 2017 from the year-ago period, while the trailing twelve-month figure was 0.06% through Dec 2017, up 29.0% year-over-year, with the annual reading at 0.09% for FY2017, 14.0% up from the prior year.
  • Return on Assets was 0.06% for Q4 2017 at Bone Biologics, up from 0.07% in the prior quarter.
  • Over five years, Return on Assets peaked at 0.06% in Q4 2017 and troughed at 0.35% in Q4 2016.